Stefano Fanti was born in Bologna, Italy, and studied at the Alma Mater Studiorum, University of Bologna, where he obtained his degree in Medicine and Surgery and later completed his specialization in Nuclear Medicine. Currently he is Associate Professor of Diagnostic Imaging and Director of the Specialty School of Nuclear Medicine at the Alma Mater Studiorum, University of Bologna. He is also Director of the Nuclear Medicine and PET Unit at the University Hospital S. Orsola-Malpighi of Bologna. Dr. Fanti is Chair of the EANM Oncology Committee (2016-2019). He is an associate editor of Clinical and Translational Imaging and an editorial board member for the European Journal of Nuclear Medicine and Molecular Imaging and the Spanish Journal of Nuclear Medicine. He has authored more than 350 articles in peer-reviewed international journals as well as a number of books and book chapters in the field of nuclear medicine.

Presents patterns of response to immunotherapy on PET/CT and conventional imaging modalities in major oncological settings

Compares functional and morphological imaging appearances in individual cases

Identifies pitfalls and immune-related adverse events that may affect image interpretation

PART I BRIEF INTRODUCTION: Immunotherapy in oncology.- Evolution of response criteria.- Part II DIESEASE-ORIENTED APPLICATIONS: CNS.- Thorax.- Melanoma.- Gastrointestinal.- Genitourinary.- Hematologic.- Other tumor types.- PART III PITFALLS AND IMMUNE-RELATED ADVERSE EVENTS (IrAEs) PART IV IMMUNO-PET.